ADEL K EL-NAGGAR to Phosphatidylinositol 3-Kinases
This is a "connection" page, showing publications ADEL K EL-NAGGAR has written about Phosphatidylinositol 3-Kinases.
Connection Strength
0.598
-
Genetic alterations in the RAS/RAF/mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways in the follicular variant of papillary thyroid carcinoma. Cancer. 2010 Jun 15; 116(12):2974-83.
Score: 0.232
-
PI3-kinase pathway biomarkers in oral cancer and tumor immune cells. Head Neck. 2019 03; 41(3):615-622.
Score: 0.104
-
Frequent PTEN loss and differential HER2/PI3K signaling pathway alterations in salivary duct carcinoma: Implications for targeted therapy. Cancer. 2018 09 15; 124(18):3693-3705.
Score: 0.103
-
Highly prevalent genetic alterations in receptor tyrosine kinases and phosphatidylinositol 3-kinase/akt and mitogen-activated protein kinase pathways in anaplastic and follicular thyroid cancers. J Clin Endocrinol Metab. 2008 Aug; 93(8):3106-16.
Score: 0.050
-
Phosphatidylinositol 3-kinase/akt and ras/raf-mitogen-activated protein kinase pathway mutations in anaplastic thyroid cancer. J Clin Endocrinol Metab. 2008 Jan; 93(1):278-84.
Score: 0.048
-
Genetic alterations and their relationship in the phosphatidylinositol 3-kinase/Akt pathway in thyroid cancer. Clin Cancer Res. 2007 Feb 15; 13(4):1161-70.
Score: 0.046
-
IQGAP1 plays an important role in the invasiveness of thyroid cancer. Clin Cancer Res. 2010 Dec 15; 16(24):6009-18.
Score: 0.015